EDGAR Filing Documents for 0001144204-17-012052

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001144204-17-012052

Filing Date

2017-03-01

Accepted

2017-03-01 14:06:39

Documents

Effectiveness Date

2017-03-01

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	12923
	Complete submission text file	0001144204-17-012052.txt		14046

Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603

Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080

XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: D | Act: 33 | File No.: 021-281565 | Film No.: 17653192
SIC: 2834 Pharmaceutical Preparations